Lonza Group AG (SWX: LONN)
Switzerland
· Delayed Price · Currency is CHF
514.60
+6.80 (1.34%)
Nov 19, 2024, 4:33 PM CET
Lonza Group AG Revenue
Lonza Group AG had revenue of 3.06B CHF in the half year ending June 30, 2024, with 2.52% growth. This brings the company's revenue in the last twelve months to 6.70B, up 5.97% year-over-year. In the year 2023, Lonza Group AG had annual revenue of 6.72B with 7.94% growth.
Revenue (ttm)
6.70B
Revenue Growth
+5.97%
P/S Ratio
5.48
Revenue / Employee
375.46K
Employees
18,000
Market Cap
36.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.72B | 494.00M | 7.94% |
Dec 31, 2022 | 6.22B | 814.00M | 15.05% |
Dec 31, 2021 | 5.41B | 901.00M | 19.99% |
Dec 31, 2020 | 4.51B | 301.00M | 7.15% |
Dec 31, 2019 | 4.21B | -1.34B | -24.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 60.58B |
Roche Holding AG | 60.58B |
Novartis AG | 42.18B |
Galderma Group AG | 3.88B |
Sonova Holding AG | 3.63B |
Straumann Holding AG | 2.54B |
Ypsomed Holding AG | 617.07M |
Galenica AG | 3.80B |
Lonza Group AG News
- 26 days ago - Lonza Sees Accelerating Sales Growth in Final Quarter - The Wall Street Journal
- 7 weeks ago - Acumen Pharmaceuticals extends collaboration with Lonza - Seeking Alpha
- 7 weeks ago - Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer's Disease - Benzinga
- 4 months ago - Lonza Group AG (LZAGY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Lonza: Acceleration In Mid-Term Sales Growth - Seeking Alpha
- 10 months ago - Lonza: Excellent Growth Projections Will Sharply Increase Free Cash Flow - Seeking Alpha
- 10 months ago - Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript - Seeking Alpha